Overcoming challenges to the implementation of antiretroviral therapy in Kenya.
Dramatic price reductions make antiretroviral drugs increasingly affordable in Africa. However, poor infrastructure, conflicting interests, and lack of commitment to a common strategy could keep them beyond the reach of most infected people. Recent experiences in Kenya, where the political will exists, show the complexity of turning this opportunity into safe and effective practice.
Taegtmeyer
Miriam
M
Liverpool School of Tropical Medicine, Liverpool, UK. MTaegtmeyer@wtnairobi.mimcom.net
Chebet
Kenneth
K
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D001294:Attitude to Health; D003695:Delivery of Health Care / Q000458:organization & administration*; D006801:Humans; D007630:Kenya; D011057:Politics
D019380:Anti-HIV Agents